Back to User profile » Dr Koji Yoshimoto

Papers published by Dr Koji Yoshimoto:

Original Research

Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status

Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Sangatsuda Y, Suzuki SO, Shono T, Mizoguchi M, Iihara K

OncoTargets and Therapy 2017, 10:429-437

Published Date: 18 January 2017

Original Research

Deferred radiotherapy and upfront procarbazine–ACNU–vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade

Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Suzuki SO, Iwaki T, Shono T, Mizoguchi M, Iihara K

OncoTargets and Therapy 2016, 9:7123-7131

Published Date: 17 November 2016

Review

Molecular biomarkers of glioblastoma: current targets and clinical implications

Yoshimoto K, Mizoguchi M, Hata N, Amano T, Nakamizo A, Sasaki T

Current Biomarker Findings 2012, 2:63-76

Published Date: 4 September 2012